Medtronic Other Non-Current Liabilities increased by 0.3% to $1.77B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $1.53B to $1.77B. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 0.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.76B | $1.58B | $1.55B | $1.42B | $1.41B | $1.44B | $1.44B | $1.73B | $1.73B | $1.72B | $1.56B | $1.41B | $1.37B | $1.47B | $1.53B | $1.53B | $1.77B | $1.81B | $1.76B | $1.77B |
| QoQ Change | — | -10.1% | -2.0% | -8.0% | -0.9% | +2.1% | -0.3% | +20.6% | -0.2% | -0.7% | -9.3% | -9.4% | -3.2% | +7.7% | +4.4% | -0.1% | +15.4% | +2.5% | -2.7% | +0.3% |
| YoY Change | — | — | — | — | -19.7% | -8.8% | -7.2% | +21.6% | +22.5% | +19.1% | +8.4% | -18.5% | -21.0% | -14.3% | -1.4% | +8.7% | +29.6% | +23.3% | +15.0% | +15.5% |